Skip links

Bio CEO & Investor Conference, February 26-27, 2024, New York, NY, US

OncoOne’s CEO, Randolf Kerschbaumer, heads to NYC for the BIOCEO24 on Feb 26-27. A key event for investors and biotech leaders, Randolf will discuss licencing and partnership opportunities for our oxMIF-targeting antibody assets, ON104 for inflammation and ON203 for immuno-oncology. OncoOne is also making strides in radiopharmaceuticals with our PreTargit® platform. Interested in learning more? Schedule a meeting with Randolf through the BIO One-on-One Partnering System. See you in New York!

Home